Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
Top Ten Searches
post partum incontinence fibroid hpv colpotomy ovarian cyst curettage endometriosis intrauterine umbilical cordYour Article Summary
See Latest ArticlesOsteoporosis and Thyrotropin-Suppressive Therapy: Reduced Effectiveness of Alendronate
Thyroid, 05/12/09
Panico A et al. - In postmenopausal women who were receiving adequate amounts of calcium and vitamin D in their diet ALN was less effective for those who were also receiving TSH-suppressive doses of LT4 for either 6 or 9 years. The positive effect of ALN on BMD was less for longer periods of LT4 treatment. It seems likely that other bisphosphonates would also be less effective in increasing BMD in postmenopausal women receiving TSH-suppressing doses of LT4.
Related Articles
Baseline glucocorticoid dose and bone mineral density response with teriparatide or alendronate therapy in patients with glucocorticoid-induced osteoporosis
Journal of Rheumatology, 11/19/09
Relevance Score: 87%
Bilateral Low-Energy Simultaneous or Sequential Femoral Fractures in Patients on Long-Term Alendronate Therapy
Journal of Bone and Joint Surgery, 11/03/09
Relevance Score: 87%
Osteoporosis and venous thromboembolism: a retrospective cohort study in the UK General Practice Research Database
Osteoporosis International, 10/12/09
Relevance Score: 87%
Use of bisphosphonates and raloxifene and risk of deep venous thromboembolism and pulmonary embolism
Osteoporosis International, 10/30/09
Relevance Score: 85%
Biomechanical effects of teriparatide in women with osteoporosis treated previously with alendronate and risedronate: Results from quantitative computed tomography-based finite element analysis of the vertebral body
Bone, 10/27/09
Relevance Score: 84%
Today in Menopausal Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
A guide to lotions and potions for treating vaginal atrophy
OBG Management, 12/02/09
Bone loss or lost bone: Rationale and recommendations for the diagnosis and treatment of early postmenopausal bone loss
Current Osteoporosis Reports, 12/02/09
Menopause, evolution and changing cultures
Menopause International, 12/02/09
Today in Reproductive Endocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
Effects of metformin with or without supplementation with folate on homocysteine levels and vascular endothelium of women with polycystic ovary syndrome
Diabetes Care, 11/30/09
Effects of Birth Weight on Anti-Mullerian Hormone Serum Concentrations in Infant Girls
Journal of Clinical Endocrinology and Metabolism, 11/30/09
Variation in the perilipin gene (PLIN) affects glucose and lipid metabolism in non-Hispanic white women with and without polycystic ovary syndrome
Diabetes Research and Clinical Practice, 11/25/09
Sponsor
Article Search
Sponsor